Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RAB5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RAB5 is a protein involved in neurodegeneration research. Key relationships include: associated with, therapeutic target, expressed in. Associated with Aging, Als, Alzheimer. Connected to 278 entities in the SciDEX knowledge graph.
| Gene Symbol | RAB5A |
| Full Name | RAB5A, member RAS oncogene family |
| Aliases | Ras-Related Protein Rab-5A |
| Chromosome | 3p24.3 |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | ~24 kDa |
| Amino Acids | 218 aa |
| Pathways | MAPK signaling |
| UniProt ID | P20339 |
| NCBI Gene ID | 5868 |
| Ensembl ID | ENSG00000112984 |
| OMIM | 171585 |
| GeneCards | RAB5A |
| Human Protein Atlas | RAB5A |
| Protein Length | 218 amino acids |
| Associated Diseases | ALS |
| Interactions | NEURODEGENERATIVE DISEASES |
| KG Connections | 32 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
RAB5["RAB5<br/>Rab5 GTPase"]
vesicle_trafficking["Vesicle<br/>Trafficking"]
endocytosis["Endocytic<br/>Pathway"]
autophagy["Autophagy<br/>Regulation"]
ATG9A["ATG9A<br/>Autophagy Gene"]
neuroprotection["Neuroprotective<br/>Mechanisms"]
cellular_homeostasis["Cellular<br/>Homeostasis"]
neurodegeneration["Neurodegeneration<br/>Process"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
dementia["Dementia<br/>Disorders"]
FTD["Frontotemporal<br/>Dementia (FTD)"]
MS["Multiple<br/>Sclerosis (MS)"]
aging["Aging-Related<br/>Decline"]
protein_aggregation["Protein<br/>Aggregation"]
synaptic_dysfunction["Synaptic<br/>Dysfunction"]
RAB5 --|"activates"|--> vesicle_trafficking
RAB5 --|"regulates"|--> endocytosis
RAB5 --|"controls"|--> autophagy
RAB5 --|"regulates"|--> ATG9A
vesicle_trafficking --|"maintains"|--> cellular_homeostasis
endocytosis --|"supports"|--> neuroprotection
autophagy --|"clears"|--> protein_aggregation
RAB5 --|"protects_against"|--> neurodegeneration
neuroprotection --|"prevents"|--> synaptic_dysfunction
neurodegeneration --|"manifests_as"|--> ALS
neurodegeneration --|"manifests_as"|--> dementia
neurodegeneration --|"manifests_as"|--> FTD
neurodegeneration --|"manifests_as"|--> MS
aging --|"accelerates"|--> neurodegeneration
protein_aggregation --|"promotes"|--> synaptic_dysfunction
synaptic_dysfunction --|"leads_to"|--> neurodegeneration
style RAB5 fill:#006494
style vesicle_trafficking fill:#1b5e20
style endocytosis fill:#1b5e20
style autophagy fill:#1b5e20
style neuroprotection fill:#1b5e20
style cellular_homeostasis fill:#1b5e20
style ATG9A fill:#4a1a6b
style neurodegeneration fill:#ef5350
style ALS fill:#5d4400
style dementia fill:#5d4400
style FTD fill:#5d4400
style MS fill:#5d4400
style aging fill:#5d4400
style protein_aggregation fill:#ef5350
style synaptic_dysfunction fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| vesicle trafficking | activates | pathway | 0.80 |
| neurodegeneration | protects_against | disease | 0.80 |
| NEURODEGENERATION | protects_against | gene | 0.80 |
| Neurodegeneration | protects_against | process | 0.80 |
| Neurodegeneration | associated_with | disease | 0.75 |
| ATG9A | regulates | gene | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| VESICLE_TRAFFICKING | regulates | pathway | 0.68 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | expressed_in | disease | 0.65 |
| Neurodegeneration | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Frontotemporal Dementia | activates | disease | 0.65 |
| Ftd | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Neuroinflammation | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Atherosclerosis | regulates | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Parkinson | interacts_with | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Frontotemporal Dementia | causes | disease | 0.65 |
| Dementia | causes | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | causes | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Ataxia | implicated_in | disease | 0.65 |
| Neurodegeneration | implicated_in | disease | 0.65 |
| Ftd | causes | disease | 0.65 |
| Ms | causes | disease | 0.65 |
| Ftd | therapeutic_target | disease | 0.65 |
| Aging | encodes | disease | 0.65 |
| Neurodegeneration | encodes | disease | 0.65 |
| Als | encodes | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURODEGENERATION | associated_with | gene | 0.70 |
| ELAVL2 | therapeutic_target | gene | 0.60 |
| C1Q | inhibits | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| CLPP | therapeutic_target | gene | 0.60 |
| RAB11 | inhibits | gene | 0.60 |
| STX17 | therapeutic_target | gene | 0.60 |
| RAB4B | associated_with | gene | 0.60 |
| RAB27B | associated_with | gene | 0.60 |
| RAB3C | associated_with | gene | 0.60 |
| OPTN | expressed_in | gene | 0.60 |
| ALS2 | expressed_in | gene | 0.60 |
| FIG4 | expressed_in | gene | 0.60 |
| C9ORF72 | protects_against | gene | 0.60 |
| PI3K | therapeutic_target | gene | 0.60 |
| BDNF | therapeutic_target | gene | 0.60 |
| SNAP29 | therapeutic_target | gene | 0.60 |
| RAB3A | associated_with | gene | 0.60 |
| RAB3B | associated_with | gene | 0.60 |
| RAB10 | associated_with | gene | 0.60 |
| RAB11B | associated_with | gene | 0.60 |
| RAB5A | associated_with | gene | 0.60 |
| SQSTM1 | expressed_in | gene | 0.60 |
| GAIN | protects_against | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| ALS2 | activates | gene | 0.60 |
| CHMP2B | expressed_in | gene | 0.60 |
| SYNAPTOPHYSIN | activates | gene | 0.60 |
| P38 | therapeutic_target | gene | 0.60 |
| IGF2BP1 | therapeutic_target | gene | 0.60 |
| FUS | therapeutic_target | gene | 0.60 |
| AKT | therapeutic_target | gene | 0.60 |
| LONP1 | therapeutic_target | gene | 0.60 |
| RAB7A | regulates | gene | 0.60 |
| ATG9A | regulates | gene | 0.60 |
| PARKIN | regulates | gene | 0.60 |
| UBIQUITIN | regulates | gene | 0.60 |
| RAB7L1 | interacts_with | gene | 0.60 |
| ARHGEF7 | interacts_with | gene | 0.60 |
| RAC1 | interacts_with | gene | 0.60 |
| LRRK2 | interacts_with | gene | 0.60 |
| RGS2 | interacts_with | gene | 0.60 |
| CDC42 | interacts_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| FUS | associated_with | gene | 0.60 |
| CHMP2B | causes | gene | 0.60 |
| FIG4 | causes | gene | 0.60 |
| ALS2 | causes | gene | 0.60 |
| IGF2BP1 | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neuroscience | 2026-04-03 | 49 hypotheses Top: 0.709
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.703
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.507
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||